{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T00:20:38Z","timestamp":1793578838192,"version":"4.5.0"},"reference-count":119,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272414"],"award-info":[{"award-number":["82272414"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014103","name":"Key Technology Research and Development Program of Shandong Province","doi-asserted-by":"publisher","award":["2022CXGC010507"],"award-info":[{"award-number":["2022CXGC010507"]}],"id":[{"id":"10.13039\/100014103","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.arr.2024.102642","type":"journal-article","created":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T19:47:04Z","timestamp":1734464824000},"page":"102642","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Biomarkers of synaptic degeneration in Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"104","author":[{"given":"Qian","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiou","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7226-3084","authenticated-orcid":false,"given":"Zhiming","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2024.102642_bib1","first-page":"1598","article-title":"Facts and figures","volume":"19","author":"2023 Alzheimer\u2019s disease","year":"2023","journal-title":"Alzheimers Dement."},{"issue":"3","key":"10.1016\/j.arr.2024.102642_bib2","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s00415-023-12066-6","article-title":"Comparison of CSF and plasma NfL and pNfH for Alzheimer's disease diagnosis: a memory clinic study","volume":"271","author":"Vrillon","year":"2023","journal-title":"J. Neurol."},{"key":"10.1016\/j.arr.2024.102642_bib3","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1002\/hbm.22005","article-title":"Resting state cortical electroencephalographic rhythms are related to gray matter volume in subjects with mild cognitive impairment and Alzheimer\u2019s disease","volume":"34","author":"Babiloni","year":"2013","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.arr.2024.102642_bib4","doi-asserted-by":"crossref","DOI":"10.15252\/msb.20199356","article-title":"Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer\u2019s disease","volume":"16","author":"Bader","year":"2020","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.arr.2024.102642_bib5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/jnnp-2022-329124","article-title":"Cerebrospinal fluid \u03b2-synuclein as a synaptic biomarker for preclinical Alzheimer\u2019s disease","volume":"94","author":"Barba","year":"2023","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2024.102642_bib6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1212\/WNL.0000000000005807","article-title":"Glutamatergic synaptic plasticity and dysfunction in Alzheimer disease: Emerging mechanisms","volume":"91","author":"Benarroch","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2024.102642_bib7","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1002\/jnr.23992","article-title":"Short-term exposure to enriched environment rescues chronic stress-induced impaired hippocampal synaptic plasticity, anxiety, and memory deficits","volume":"95","author":"Bhagya","year":"2017","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.arr.2024.102642_bib8","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.neuron.2017.10.006","article-title":"Transcellular nanoalignment of synaptic function","volume":"96","author":"Biederer","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2024.102642_bib9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41593-018-0289-8","article-title":"Tau impairs neural circuits, dominating amyloid-\u03b2 effects, in Alzheimer models in vivo","volume":"22","author":"Busche","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.arr.2024.102642_bib10","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","article-title":"Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease","volume":"20","author":"Butterfield","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.arr.2024.102642_bib11","doi-asserted-by":"crossref","first-page":"6747","DOI":"10.1038\/s41467-023-42596-6","article-title":"Plasma biomarkers predict Alzheimer\u2019s disease before clinical onset in Chinese cohorts","volume":"14","author":"Cai","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2024.102642_bib12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s13195-022-01133-1","article-title":"Proteomic profiling of circulating plasma exosomes reveals novel biomarkers of Alzheimer\u2019s disease","volume":"14","author":"Cai","year":"2022","journal-title":"Alzheimers Res. Ther."},{"issue":"1","key":"10.1016\/j.arr.2024.102642_bib13","first-page":"S310","article-title":"Role of the brain-derived neurotrophic factor at glutamatergic synapses","volume":"153","author":"Carvalho","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.arr.2024.102642_bib14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40658-021-00384-5","article-title":"Human biodistribution and dosimetry of [11C]-UCB-J, a PET radiotracer for imaging synaptic density","volume":"8","author":"Cawthorne","year":"2021","journal-title":"EJNMMI Phys."},{"key":"10.1016\/j.arr.2024.102642_bib15","doi-asserted-by":"crossref","first-page":"902","DOI":"10.3389\/fphar.2019.00902","article-title":"Mitochondria as potential targets in Alzheimer disease therapy: an update","volume":"10","author":"Cenini","year":"2019","journal-title":"Front. Pharm."},{"key":"10.1016\/j.arr.2024.102642_bib16","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s00415-018-9016-3","article-title":"Magnetic resonance imaging in Alzheimer\u2019s disease and mild cognitive impairment","volume":"266","author":"Chandra","year":"2019","journal-title":"J. Neurol."},{"key":"10.1016\/j.arr.2024.102642_bib17","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/jnc.15128","article-title":"Plasma metabolites associated with biomarker evidence of neurodegeneration in cognitively normal older adults","volume":"159","author":"Chatterjee","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2024.102642_bib18","doi-asserted-by":"crossref","first-page":"7228","DOI":"10.18632\/aging.202580","article-title":"Evaluating the association between brain atrophy, hypometabolism, and cognitive decline in Alzheimer\u2019s disease: a PET\/MRI study","volume":"13","author":"Chen","year":"2021","journal-title":"Aging"},{"key":"10.1016\/j.arr.2024.102642_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.988143","article-title":"Integrated bioinformatics-based identification of diagnostic markers in Alzheimer disease","volume":"14","author":"Chen","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2024.102642_bib20","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1016\/j.neuron.2023.04.020","article-title":"Synaptic oligomeric tau in Alzheimer\u2019s disease - a potential culprit in the spread of tau pathology through the brain","volume":"111","author":"Colom-Cadena","year":"2023","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2024.102642_bib21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13195-020-00588-4","article-title":"The clinical promise of biomarkers of synapse damage or loss in Alzheimer\u2019s disease","volume":"12","author":"Colom-Cadena","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.arr.2024.102642_bib22","first-page":"107","article-title":"Neuropathological and biomarker findings in parkinson\u2019s disease and Alzheimer\u2019s disease: from protein aggregates to synaptic dysfunction","volume":"11","author":"Compta","year":"2021","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.arr.2024.102642_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/s41582-023-00883-2","article-title":"Tau-targeting therapies for Alzheimer disease: current status and future directions","author":"Congdon","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2024.102642_bib24","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/jnnp-2022-330958","article-title":"Blood biomarkers: ready for clinical practice?","volume":"94","author":"Coulthard","year":"2023","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2024.102642_bib25","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41582-020-0400-0","article-title":"Complement in neurological disorders and emerging complement-targeted therapeutics","volume":"16","author":"Dalakas","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2024.102642_bib26","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3233\/JAD-201038","article-title":"\u03b1-Synuclein heteromers in red blood cells of Alzheimer\u2019s disease and Lewy body dementia patients","volume":"80","author":"Daniele","year":"2021","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2024.102642_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001908","article-title":"Palmitoylation of gephyrin controls receptor clustering and plasticity of GABAergic synapses","volume":"12","author":"Dejanovic","year":"2014","journal-title":"PLoS Biol."},{"key":"10.1016\/j.arr.2024.102642_bib28","article-title":"Targeting synapse function and loss for treatment of neurodegenerative diseases","author":"Dejanovic","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.arr.2024.102642_bib29","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3389\/fnagi.2018.00190","article-title":"EEG characteristics of dementia with lewy bodies, Alzheimer\u2019s disease and mixed pathology","volume":"10","author":"van der Zande","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2024.102642_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.nlm.2021.107480","article-title":"Ceftriaxone regulates glutamate production and vesicular assembly in presynaptic terminals through GLT-1 in APP\/PS1 mice","volume":"183","author":"Fan","year":"2021","journal-title":"Neurobiol. Learn Mem."},{"key":"10.1016\/j.arr.2024.102642_bib31","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1021\/acschemneuro.0c00811","article-title":"A\u03b2 oligomers dysregulate calcium homeostasis by mechanosensitive activation of AMPA and NMDA receptors","volume":"12","author":"Fani","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2024.102642_bib32","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.molmed.2023.07.010","article-title":"Oligodendrocyte pathology in Huntington\u2019s disease: from mechanisms to therapeutics","volume":"29","author":"Ferrari Bardile","year":"2023","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.arr.2024.102642_bib33","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.tins.2017.04.002","article-title":"Synaptic impairment in Alzheimer\u2019s disease: a dysregulated symphony","volume":"40","author":"Forner","year":"2017","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.arr.2024.102642_bib34","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41467-023-44374-w","article-title":"Elevated CSF GAP-43 is associated with accelerated tau accumulation and spread in Alzheimer\u2019s disease","volume":"15","author":"Franzmeier","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2024.102642_bib35","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.neuron.2015.12.034","article-title":"IGF-1 receptor differentially regulates spontaneous and evoked transmission via mitochondria at Hippocampal synapses","volume":"89","author":"Gazit","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2024.102642_bib36","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1007\/s00415-022-11055-5","article-title":"Plasma neurofilament light chain as a biomarker of Alzheimer\u2019s disease in subjective cognitive decline and mild cognitive impairment","volume":"269","author":"Giacomucci","year":"2022","journal-title":"J. Neurol."},{"key":"10.1016\/j.arr.2024.102642_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099184","article-title":"Inhibition of the polyamine system counteracts \u03b2-amyloid peptide-induced memory impairment in mice: involvement of extrasynaptic NMDA receptors","volume":"9","author":"Gomes","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2024.102642_bib38","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.neuron.2021.02.014","article-title":"Targeting pre-synaptic tau accumulation: a new strategy to counteract tau-mediated synaptic loss and memory deficits","volume":"109","author":"Gratuze","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2024.102642_bib39","doi-asserted-by":"crossref","first-page":"e887","DOI":"10.1212\/WNL.0000000000005057","article-title":"Neurogranin as a predictor of memory and executive function decline in MCI patients","volume":"90","author":"Headley","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2024.102642_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz9360","article-title":"Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer\u2019s disease","volume":"6","author":"Higginbotham","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.arr.2024.102642_bib41","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3389\/fncel.2017.00266","article-title":"A SHift from A Pivotal to Supporting Role for the Growth-associated protein (GAP-43) in the coordination of axonal structural and functional plasticity","volume":"11","author":"Holahan","year":"2017","journal-title":"Front. Cell Neurosci."},{"key":"10.1016\/j.arr.2024.102642_bib42","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.aad8373","article-title":"Complement and microglia mediate early synapse loss in Alzheimer mouse models","volume":"352","author":"Hong","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.arr.2024.102642_bib43","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuron.2018.06.003","article-title":"Dendritic Tau in Alzheimer\u2019s disease","volume":"99","author":"Ittner","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2024.102642_bib44","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/alz.12166","article-title":"Blood neuro-exosomal synaptic proteins predict Alzheimer\u2019s disease at the asymptomatic stage","volume":"17","author":"Jia","year":"2021","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2024.102642_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101208","article-title":"Synaptic basis of Alzheimer\u2019s disease: focus on synaptic amyloid beta, P-tau and mitochondria","volume":"65","author":"John","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2024.102642_bib46","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/nrn2234","article-title":"Synaptic plasticity and addiction","volume":"8","author":"Kauer","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.arr.2024.102642_bib47","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13195-022-01002-x","article-title":"Increased levels of the synaptic proteins PSD-95, SNAP-25, and neurogranin in the cerebrospinal fluid of patients with Alzheimer\u2019s disease","volume":"14","author":"Kivis\u00e4kk","year":"2022","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.arr.2024.102642_bib48","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/jnc.14797","article-title":"Synaptophysin sustains presynaptic performance by preserving vesicular synaptobrevin-II levels","volume":"151","author":"Kokotos","year":"2019","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2024.102642_bib49","article-title":"Resting-state EEG signatures of Alzheimer\u2019s disease are driven by periodic but not aperiodic changes","author":"Kop\u010danov\u00e1","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2024.102642_bib50","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1515\/cclm-2015-1195","article-title":"Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa","volume":"54","author":"Kuhle","year":"2016","journal-title":"Clin. Chem. Lab Med."},{"key":"10.1016\/j.arr.2024.102642_bib51","doi-asserted-by":"crossref","first-page":"9540","DOI":"10.3390\/ijms23179540","article-title":"Dysfunctional glucose metabolism in Alzheimer\u2019s disease onset and potential pharmacological interventions","volume":"23","author":"Kumar","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2024.102642_bib52","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.jalz.2014.10.009","article-title":"Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer\u2019s disease","volume":"11","author":"Kvartsberg","year":"2015","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2024.102642_bib53","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1523\/JNEUROSCI.3501-06.2007","article-title":"Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer\u2019s disease","volume":"27","author":"Lacor","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2024.102642_bib54","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.neurobiolaging.2023.09.012","article-title":"Association of APOE-\u03b54 and GAP-43-related presynaptic loss with \u03b2-amyloid, tau, neurodegeneration, and cognitive decline","volume":"132","author":"Lan","year":"2023","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2024.102642_bib55","doi-asserted-by":"crossref","first-page":"16857","DOI":"10.1523\/JNEUROSCI.1858-12.2012","article-title":"The complex PrP(c)-Fyn couples human oligomeric A\u03b2 with pathological tau changes in Alzheimer\u2019s disease","volume":"32","author":"Larson","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2024.102642_bib56","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/nature07761","article-title":"Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers.","volume":"457","author":"Laur\u00e9n","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.arr.2024.102642_bib57","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/WCO.0000000000000904","article-title":"Current advances in plasma and cerebrospinal fluid biomarkers in Alzheimer\u2019s disease","volume":"34","author":"Leuzy","year":"2021","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.arr.2024.102642_bib58","doi-asserted-by":"crossref","DOI":"10.1177\/0271678X241230733","article-title":"The associations between synaptic density and \u201cA\/T\/N\u201d biomarkers in Alzheimer\u2019s disease: an 18F-SynVesT-1 PET\/MR study","author":"Li","year":"2024","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.arr.2024.102642_bib59","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1002\/alz.12353","article-title":"Longitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer\u2019s disease","volume":"17","author":"Libiger","year":"2021","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2024.102642_bib60","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41398-020-0801-2","article-title":"Neurogranin as a cognitive biomarker in cerebrospinal fluid and blood exosomes for Alzheimer\u2019s disease and mild cognitive impairment","volume":"10","author":"Liu","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.arr.2024.102642_bib61","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1007\/s40520-022-02202-z","article-title":"Cerebrospinal fluid growth-associated protein 43 levels in patients with progressive and stable mild cognitive impairment","volume":"34","author":"Lu","year":"2022","journal-title":"Aging Clin. Exp. Res."},{"key":"10.1016\/j.arr.2024.102642_bib62","volume":"27","author":"Lv","year":"2021","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.arr.2024.102642_bib63","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1146\/annurev.neuro.23.1.649","article-title":"Synaptic plasticity and memory: an evaluation of the hypothesis","volume":"23","author":"Martin","year":"2000","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.arr.2024.102642_bib64","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/jamaneurol.2016.6117","article-title":"Association of plasma neurofilament light with neurodegeneration in patients With Alzheimer disease","volume":"74","author":"Mattsson","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2024.102642_bib65","doi-asserted-by":"crossref","first-page":"e2065","DOI":"10.1212\/WNL.0000000000012853","article-title":"CSF synaptic biomarkers in the preclinical stage of Alzheimer disease and their association with MRI and PET: a cross-sectional study","volume":"97","author":"Mil\u00e0-Alom\u00e0","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2024.102642_bib66","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13195-022-01021-8","article-title":"Quantification of SNAP-25 with mass spectrometry and Simoa: a method comparison in Alzheimer\u2019s disease","volume":"14","author":"Nilsson","year":"2022","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.arr.2024.102642_bib67","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1002\/alz.12809","article-title":"Cerebrospinal fluid biomarker panel of synaptic dysfunction in Alzheimer\u2019s disease and other neurodegenerative disorders","volume":"19","author":"Nilsson","year":"2023","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2024.102642_bib68","article-title":"Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer\u2019s disease","volume":"13","author":"Nilsson","year":"2021","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2024.102642_bib69","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s10072-023-07028-9","article-title":"Quantitative electroencephalography (qEEG), apolipoprotein A-I (APOA-I), and apolipoprotein epsilon 4 (APOE \u025b4) alleles for the diagnosis of mild cognitive impairment and Alzheimer\u2019s disease","volume":"45","author":"Niu","year":"2024","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.arr.2024.102642_bib70","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/alz.12790","article-title":"Relationship of serum beta-synuclein with blood biomarkers and brain atrophy","volume":"19","author":"Oeckl","year":"2023","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2024.102642_bib71","doi-asserted-by":"crossref","first-page":"4896","DOI":"10.1002\/alz.13046","article-title":"Blood \u03b2-synuclein is related to amyloid PET positivity in memory clinic patients","volume":"19","author":"Oeckl","year":"2023","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2024.102642_bib72","doi-asserted-by":"crossref","first-page":"5095","DOI":"10.1002\/alz.13103","article-title":"Higher plasma \u03b2-synuclein indicates early synaptic degeneration in Alzheimer\u2019s disease","volume":"19","author":"Oeckl","year":"2023","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2024.102642_bib73","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13195-020-00748-6","article-title":"Full-length and C-terminal neurogranin in Alzheimer\u2019s disease cerebrospinal fluid analyzed by novel ultrasensitive immunoassays","volume":"12","author":"\u00d6hrfelt","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.arr.2024.102642_bib74","article-title":"Microglial activation, tau and amyloid deposition in TREM2 p.R47H carriers and mild cognitive impairment patients: a multi-modal\/multi-tracer PET\/MRI imaging study with influenza vaccine immune challenge","volume":"20","author":"Oliver","year":"2023","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.arr.2024.102642_bib75","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.ajhg.2019.03.010","article-title":"Homozygous Mutations in CSF1R Cause a Pediatric-Onset Leukoencephalopathy and Can Result in Congenital Absence of Microglia","volume":"104","author":"Oosterhof","year":"2019","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.arr.2024.102642_bib76","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41583-021-00531-y","article-title":"Super-resolution microscopy: a closer look at synaptic dysfunction in Alzheimer disease","volume":"22","author":"Padmanabhan","year":"2021","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.arr.2024.102642_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102359","article-title":"Proteomics profiling of extracellular vesicle for identification of potential biomarkers in Alzheimer\u2019s disease: a comprehensive review","volume":"99","author":"Pei","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2024.102642_bib78","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/brain\/awaa395","article-title":"Untangling the association of amyloid-\u03b2 and tau with synaptic and axonal loss in Alzheimer\u2019s disease","volume":"144","author":"Pereira","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.arr.2024.102642_bib79","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3389\/fnagi.2013.00058","article-title":"Integrative EEG biomarkers predict progression to Alzheimer\u2019s disease at the MCI stage","volume":"5","author":"Poil","year":"2013","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2024.102642_bib80","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41591-018-0304-3","article-title":"Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer\u2019s disease","volume":"25","author":"Preische","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2024.102642_bib81","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1002\/alz.12645","article-title":"Early dementia diagnosis, MCI-to-dementia risk prediction, and the role of machine learning methods for feature extraction from integrated biomarkers, in particular for EEG signal analysis","volume":"18","author":"Rossini","year":"2022","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2024.102642_bib82","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.3233\/JAD-220515","article-title":"Synaptic proteins as fluid biomarkers in Alzheimer\u2019s disease: a systematic review and meta-analysis","volume":"90","author":"Roveta","year":"2022","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2024.102642_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.105991","article-title":"Neurogranin in Alzheimer\u2019s disease and ageing: a human post-mortem study","volume":"177","author":"Saunders","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2024.102642_bib84","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer\u2019s disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.arr.2024.102642_bib85","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1474-4422(20)30412-9","article-title":"APOE and Alzheimer\u2019s disease: advances in genetics, pathophysiology, and therapeutic approaches","volume":"20","author":"Serrano-Pozo","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2024.102642_bib86","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jagp.2023.08.002","article-title":"Assessment of gray matter microstructure and synaptic density in Alzheimer\u2019s disease: a multimodal imaging study with DTI and SV2A PET","volume":"32","author":"Silva-Rudberg","year":"2024","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.arr.2024.102642_bib87","first-page":"CD010632","article-title":"18F-FDG PET for the early diagnosis of Alzheimer\u2019s disease dementia and other dementias in people with mild cognitive impairment (MCI)","volume":"1","author":"Smailagic","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.arr.2024.102642_bib88","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3233\/JAD-220165","article-title":"Incidental finding: urine Alzheimer-associated neuronal thread protein (AD7c-NTP) and serum vitamin D25","volume":"89","author":"Song","year":"2022","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2024.102642_bib89","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature25143","article-title":"Enhancing mitochondrial proteostasis reduces amyloid-\u03b2 proteotoxicity","volume":"552","author":"Sorrentino","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.arr.2024.102642_bib90","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201898960","article-title":"Parkinson\u2019s disease: convergence on synaptic homeostasis","volume":"37","author":"Soukup","year":"2018","journal-title":"EMBO J."},{"key":"10.1016\/j.arr.2024.102642_bib91","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.neuron.2014.05.004","article-title":"The intersection of amyloid beta and tau at synapses in Alzheimer\u2019s disease","volume":"82","author":"Spires-Jones","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2024.102642_bib92","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11910-010-0104-8","article-title":"Synapse pathology in psychiatric and neurologic disease","volume":"10","author":"van Spronsen","year":"2010","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.arr.2024.102642_bib93","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuron.2012.06.012","article-title":"The presynaptic active zone","volume":"75","author":"S\u00fcdhof","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2024.102642_bib94","article-title":"Exploring frequency band-based biomarkers of EEG signals for mild cognitive impairment detection","author":"Tawhid","year":"2023","journal-title":"IEEE Trans. Neural Syst. Rehabil. Eng."},{"key":"10.1016\/j.arr.2024.102642_bib95","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","article-title":"Physical basis of cognitive alterations in Alzheimer\u2019s disease: synapse loss is the major correlate of cognitive impairment","volume":"30","author":"Terry","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2024.102642_bib96","doi-asserted-by":"crossref","first-page":"e953","DOI":"10.1212\/WNL.0000000000010131","article-title":"Dissection of synaptic pathways through the CSF biomarkers for predicting Alzheimer disease","volume":"95","author":"Tible","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2024.102642_bib97","article-title":"Human astrocytes and microglia show augmented ingestion of synapses in Alzheimer\u2019s disease via MFG-E8","volume":"4","author":"Tzioras","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.arr.2024.102642_bib98","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41582-022-00749-z","article-title":"Synaptic degeneration in Alzheimer disease","volume":"19","author":"Tzioras","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2024.102642_bib99","doi-asserted-by":"crossref","first-page":"470","DOI":"10.2174\/1389203722666210325110231","article-title":"Synaptotagmin-1: a multi-functional protein that mediates vesicle docking, priming, and fusion","volume":"22","author":"Ullah","year":"2021","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.arr.2024.102642_bib100","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.682115","article-title":"Cerebrospinal fluid of patients with Alzheimer\u2019s disease contains increased percentages of synaptophysin-bearing microvesicles","volume":"13","author":"Utz","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2024.102642_bib101","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.3390\/cells11081367","article-title":"Blood-based biomarkers for Alzheimer\u2019s disease diagnosis and progression: an overview","volume":"11","author":"Varesi","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.arr.2024.102642_bib102","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40035-021-00278-7","article-title":"Excitotoxicity, calcium and mitochondria: a triad in synaptic neurodegeneration","volume":"11","author":"Verma","year":"2022","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.arr.2024.102642_bib103","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1007\/s12035-015-9143-0","article-title":"The essential role of soluble A\u03b2 oligomers in Alzheimer\u2019s disease","volume":"53","author":"Wang","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2024.102642_bib104","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1186\/s40001-023-01360-8","article-title":"SNAP25 is a potential target for early stage Alzheimer\u2019s disease and Parkinson\u2019s disease","volume":"28","author":"Wang","year":"2023","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.arr.2024.102642_bib105","article-title":"Complement-mediated synapse loss in Alzheimer\u2019s disease: mechanisms and involvement of risk factors","author":"Wen","year":"2023","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.arr.2024.102642_bib106","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","article-title":"Hallmarks of neurodegenerative diseases","volume":"186","author":"Wilson","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.arr.2024.102642_bib107","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/j.celrep.2019.07.060","article-title":"Complement C3 is activated in human AD brain and is required for neurodegeneration in mouse models of Amyloidosis and Tauopathy","volume":"28","author":"Wu","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.arr.2024.102642_bib108","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40035-021-00270-1","article-title":"The role of pathological tau in synaptic dysfunction in Alzheimer\u2019s diseases","volume":"10","author":"Wu","year":"2021","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.arr.2024.102642_bib109","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.23798","article-title":"NPTX2 and cognitive dysfunction in Alzheimer\u2019s Disease","volume":"6","author":"Xiao","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.arr.2024.102642_bib110","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41583-022-00624-2","article-title":"CaMKII: a central molecular organizer of synaptic plasticity, learning and memory","volume":"23","author":"Yasuda","year":"2022","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.arr.2024.102642_bib111","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.671779","article-title":"Dendritic\/Post-synaptic Tau and early pathology of Alzheimer\u2019s Disease","volume":"14","author":"Yin","year":"2021","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.arr.2024.102642_bib112","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","article-title":"Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model","volume":"53","author":"Yoshiyama","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2024.102642_bib113","doi-asserted-by":"crossref","DOI":"10.3233\/JAD-230485","article-title":"Quantitative EEG spectral and connectivity analysis for cognitive decline in amnestic mild cognitive impairment","author":"Zawi\u015blak-Fornagiel","year":"2024","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2024.102642_bib114","article-title":"Role of A\u03b2 in Alzheimer\u2019s-related synaptic dysfunction","volume":"10","author":"Zhang","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.arr.2024.102642_bib115","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1177\/0271678X231153730","article-title":"In vivo synaptic density loss correlates with impaired functional and related structural connectivity in Alzheimer\u2019s disease","volume":"43","author":"Zhang","year":"2023","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.arr.2024.102642_bib116","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.immuni.2023.06.016","article-title":"TREM2 receptor protects against complement-mediated synaptic loss by binding to complement C1q during neurodegeneration","volume":"56","author":"Zhong","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.arr.2024.102642_bib117","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adf0141","article-title":"The neuronal pentraxin Nptx2 regulates complement activity and restrains microglia-mediated synapse loss in neurodegeneration","volume":"15","author":"Zhou","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.arr.2024.102642_bib118","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neulet.2017.04.027","article-title":"Plasma neurofilament light chain levels in Alzheimer\u2019s disease","volume":"650","author":"Zhou","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2024.102642_bib119","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1016\/j.neurobiolaging.2015.04.005","article-title":"Ceftriaxone ameliorates tau pathology and cognitive decline via restoration of glial glutamate transporter in a mouse model of Alzheimer\u2019s disease","volume":"36","author":"Zumkehr","year":"2015","journal-title":"Neurobiol. Aging"}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163724004604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163724004604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T20:19:25Z","timestamp":1740601165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163724004604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":119,"alternative-id":["S1568163724004604"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2024.102642","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers of synaptic degeneration in Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2024.102642","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102642"}}